David C. Hanley's most recent trade in Nuvation Bio Inc - Ordinary Shares - Class A was a trade of 500,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvation Bio Inc - Ordinar... | David C. Hanley | CHIEF TECHNICAL OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc - Ordinar... | David C. Hanley | CHIEF TECHNICAL OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc - Ordinar... | David C. Hanley | Chief Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) |